Perfect Medical Health Management Limited’s (HKG:1830) Subdued P/E Might Signal An Opportunity

With a price-to-earnings (or “P/E”) ratio of 8.6x Perfect Medical Health Management Limited (HKG:1830) may be sending bullish signals at the moment, given that almost half of all companies in Hong Kong have P/E ratios greater than 11x and even P/E’s higher than 22x are not unusual. Although, it’s not wise to just take the P/E at face value as there may be an explanation why it’s limited.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

While the market has experienced earnings growth lately, Perfect Medical Health Management’s earnings have gone into reverse gear, which is not great. It seems that many are expecting the dour earnings performance to persist, which has repressed the P/E. If you still like the company, you’d be hoping this isn’t the case so that you could potentially pick up some stock while it’s out of favour.

Check out our latest analysis for Perfect Medical Health Management

If you’d like to see what analysts are forecasting going forward, you should check out our free report on Perfect Medical Health Management .

What Are Growth Metrics Telling Us About The Low P/E?

There’s an inherent assumption that a company should underperform the market for P/E ratios like Perfect Medical Health Management’s to be considered reasonable.

Retrospectively, the last year delivered a frustrating 12% decrease to the company’s bottom line. This means it has also seen a slide in earnings over the longer-term as EPS is down 23% in total over the last three years. Accordingly, shareholders would have felt downbeat about the medium-term rates of earnings growth.

Shifting to the future, estimates from the one analyst covering the company suggest earnings should grow by 15% each year over the next three years. Meanwhile, the rest of the market is forecast to expand by 14% per year, which is not materially different.

In light of this, it’s peculiar that Perfect Medical Health Management’s P/E sits below the majority of other companies. Apparently some shareholders are doubtful of the forecasts and have been accepting lower selling prices.

The Key Takeaway

Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.

We’ve established that Perfect Medical Health Management currently trades on a lower than expected P/E since its forecast growth is in line with the wider market. There could be some unobserved threats to earnings preventing the P/E ratio from matching the outlook. It appears some are indeed anticipating earnings instability, because these conditions should normally provide more support to the share price.

Before you take the next step, you should know about the 1 warning sign for Perfect Medical Health Management that we have uncovered.

Of course, you might find a fantastic investment by looking at a few good candidates. So take a peek at this free list of companies with a strong growth track record, trading on a low P/E.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.